acetylgalactosamine has been researched along with Hyperlipidemias in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Biessen, EA; Rensen, PC; Sliedregt, LA; van Berkel, TJ; van Leeuwen, SH | 1 |
Biessen, EA; Ferns, M; Rensen, PC; Schifferstein, HN; Sliedregt, LA; Souverijn, JH; van Berkel, TJ; van Leeuwen, SH; van Santbrink, PJ | 1 |
2 other study(ies) available for acetylgalactosamine and Hyperlipidemias
Article | Year |
---|---|
Design and synthesis of novel N-acetylgalactosamine-terminated glycolipids for targeting of lipoproteins to the hepatic asialoglycoprotein receptor.
Topics: Acetylgalactosamine; Animals; Anticholesteremic Agents; Asialoglycoprotein Receptor; Blood Proteins; Drug Design; Glycolipids; Humans; Hyperlipidemias; Iodine Radioisotopes; Isotope Labeling; Lipoproteins, HDL; Lipoproteins, LDL; Liver; Mice; Mice, Inbred C57BL; Mice, Knockout; Protein Binding; Receptors, LDL | 2004 |
Stimulation of liver-directed cholesterol flux in mice by novel N-acetylgalactosamine-terminated glycolipids with high affinity for the asialoglycoprotein receptor.
Topics: Acetylgalactosamine; Animals; Apolipoproteins E; Asialoglycoprotein Receptor; Atherosclerosis; Cholesterol; Glycolipids; Hyperlipidemias; Lipoproteins, HDL; Lipoproteins, LDL; Liver; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Spleen | 2006 |